Drugmakers Share Confidential Data to Aid in Olympic Drug Tests

Feb 11, 2014

ABC News

Some of the world's largest drug manufacturers are playing a larger role in anti-doping efforts at the 2014 Winter Olympics. They're providing information on drugs that once would have been considered proprietary trade secrets. GlaxoSmithKline, Amgen and Roche are among the companies that have begun sharing "confidential research and data" with anti-doping officials about experimental drugs they are developing. Read the full story

Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments